Abstract
The pharmacological preparation P-4 administered according to a reduced scheme (the first dose, 1.5–2 h before stimulation; the second dose, 2 h after stimulation) efficiently alleviated the main symptoms of motion sickness, accelerated the process of adaptation and increased its efficiency in persons prone to motion sickness upon exposure to slow rotation during four days. Administration of the preparation according to the scheme described above did not cause the abstinence syndrome.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Meditisnskoe obespechenie kosmicheskih poletov, vol. 1 of Orbital’naya stantsiya Mir. Kosmicheskaya biologiya i medicina v dvukh tomakh (Medical Care during Spaceflights, vol. 1 of The Mir Orbital Station: Aerospace Biology and Medicine, in Two Volumes). Moscow, 2001.
Grigor’ev, A.I., Egorov, A.D., Phenomenology and Mechanism of the Changes in the Basal Function of the Human Organism in the Absence of Gravitation, Kosm. Biol. Aviakosm. Med., 1988, vol. 22, no. 6, p. 3.
Galle, R.R., Modeling of the Space Form of Motion Sickness, 1983, no. 3, p. 74.
Galle, R.R., Quantitative Assessment of the Clinical Manifestations of Motion Sickness, 1981, no. 3, pp. 72.
Graybiel, A., Space Motion Sickness: Skylab Revisited, Aviat. Space Environ. Med., 1980, vol. 51, no. 6, p. 814.
Author information
Authors and Affiliations
Additional information
Original Russian Text © O.I. Orlov, 2007, published in Aviakosmicheskaya i Ekologicheskaya Meditsina, 2007, Vol. 41, No. 6, pp. 24–28.
Rights and permissions
About this article
Cite this article
Orlov, O.I. Assessment of the effect of pharmaceuticals used to treat motion sickness on adaptation to model conditions involving prolonged rotation. Hum Physiol 38, 757–762 (2012). https://doi.org/10.1134/S0362119712070195
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0362119712070195